Abstract | BACKGROUND: Treatment of nail psoriasis remains a challenge. OBJECTIVE: METHODS: Twenty-five psoriatic patients with nail involvement and mild cutaneous psoriasis were instructed to apply a calcipotriol- betamethasone valerate ointment formulation once daily for 12 weeks on affected nails. Outcome measures were assessed at baseline and at weeks 4, 8 and 12 using the nail psoriasis severity index (NAPSI). RESULTS: Twenty-two patients having 114 nails involved at baseline with a mean NAPSI of 5.8 +/- 1.7 were followed up for 12 weeks. The mean NAPSI at the end of the treatment period was reduced to 1.6 +/- 0.6 presenting a 72% improvement. Significant improvement was observed for hyperkeratosis and onycholysis (reduction of mean hyperkeratosis NAPSI from 2.2 +/- 0.5 to 0.5 +/- 0.1 and mean onycholysis NAPSI from 2.0 +/- 0.6 to 0.4 +/- 0.2), moderate improvement for oil drops (reduction of mean oil drop NAPSI from 1.2 +/- 0.4 to 0.8 +/- 0.3) and slight improvement for pitting (reduction of mean pitting NAPSI from 0.8 +/- 0.2 to 0.6 +/- 0.2). CONCLUSIONS:
|
Authors | D Rigopoulos, S Gregoriou, C R Daniel Iii, H Belyayeva, G Larios, P Verra, C Stamou, G Kontochristopoulos, G Avgerinou, A Katsambas |
Journal | Dermatology (Basel, Switzerland)
(Dermatology)
Vol. 218
Issue 4
Pg. 338-41
( 2009)
ISSN: 1421-9832 [Electronic] Switzerland |
PMID | 19212110
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | Copyright 2009 S. Karger AG, Basel. |
Chemical References |
- Dermatologic Agents
- Drug Combinations
- Ointments
- calcipotriene
- betamethasone-17,21-dipropionate
- Betamethasone
- Calcitriol
|
Topics |
- Betamethasone
(administration & dosage, analogs & derivatives)
- Calcitriol
(administration & dosage, analogs & derivatives)
- Dermatologic Agents
(administration & dosage)
- Drug Combinations
- Humans
- Nail Diseases
(drug therapy)
- Ointments
- Psoriasis
(drug therapy)
|